Consideration for the License Clause Samples

POPULAR SAMPLE Copied 1 times
Consideration for the License. The consideration for the grant of the license to YAK shall be One Hundred Thousand Dollars ($100,000). Simultaneously with the execution of this Agreement by the parties hereto, YAK shall pay to MainStreet the sum of twenty-five thousand ($25,000.00) dollars as initial payment on account of the full consideration, receipt of which is hereby acknowledged by MainStreet. Notwithstanding anything to the contrary contained herein, no portion of the initial payment shall be refundable under any circumstances. Upon a successful offering wherein all shares have been sold within the Offering Period, YAK shall then instruct the Escrow Agent to deduct from the proceeds of the public offering the sum of seventy-five thousand dollars ($75,000.00) and remit such sum directly to MainStreet. In the event that fewer than all of the shares offered have been sold within the Offering Period, the sum of seventy-five thousand ($75,000.00) shall nonetheless be due and payable to MainStreet within ten (10) days after the termination of the offering.
Consideration for the License. The foregoing trademark license is being granted by VANIGLIA E CIOCCOLATO, INC., in consideration to the supply and distribution agreement being also entered between the parties by virtue of the ensuing provision, and from which both VANIGLIA E CIOCCOLATO, INC. and VANIGLIA E CIOCCOLATO LAB INC. will obtainfinancial gain, namely, the selling price of the products that will be sold by VANIGLIA E CIOCCOLATO LAB INC. to DIVINITUS, LLC.
Consideration for the License. In consideration for Licensor’s grant of the right and license to use the Licensed Marks as provided herein, Licensee shall issue to Licensor 0.6512 shares of common stock of Licensee (the “Licensee Shares”), such that, following the issuance of the Licensee Shares, Licensor shall own, free and clear of all liens, 0.6512 shares of common stock of Licensee, which represent all of the issued and outstanding shares of Licensee.
Consideration for the License. As a condition of the grant to use the TCK above, Licensee shall provide the consideration set forth in Exhibit A. Any fee or royalty payments required shall be sent to: Oracle America, Inc., Software Royalty Accounting Group, ▇▇ ▇▇▇ ▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇ ▇▇ ▇▇▇▇▇.
Consideration for the License. In consideration of the rights granted under this Agreement Cougar shall pay to ▇▇▇ the following: (a) [***] upon commencement of this Agreement; (b) [***] upon completion of a Cougar sponsored (or sublicensee sponsored) Phase II Proof of Concept trial with a Product that achieves its primary endpoint as defined in the study protocol; (c) [***] upon the dosing of the first patient with a Product in a Cougar sponsored (or sublicensee sponsored) pivotal Phase III clinical trial; (d) [***] upon submission of the first Cougar sponsored (or sublicensee sponsored) New Drug Application by the Food and Drug Administration with a Product; (e) [***] upon the final approval by the Food and Drug Administration of the first Cougar sponsored (or sublicensee sponsored) New Drug Application for a Product; and (f) [***] upon the first final approval by the applicable regulatory agency in the European Union of the first Cougar sponsored (or sublicensee sponsored) application for a Product. Payment shall be made within 15 (fifteen) working days from the date mentioned in the relevant section by bank transfer to such bank account as designated by ▇▇▇ in writing.
Consideration for the License. A. Licensor shall acquire a 51% (fifty-one percent) equity interest in SOS. This equity interest will survive the term of this Agreement and will continue, subject to the same terms and conditions as other equity interests in SOS. B. Licensee will purchase the DAF assets of Licensor for an amount of $100,000. C. There will be no ongoing licensing or royalty payments of any kind from SOS to SIONIX.
Consideration for the License. 3.1 Subject to the terms and conditions of this Agreement, in consideration of the rights, privileges and license granted hereunder, the Company shall make payments to the Licensor as set forth in, and in accordance with the provisions of, this Article 3. 3.2 The Licensor will make the following payments in consideration of this license: 3.2.1 A non-refundable payment of $[**] upon the execution of this Agreement (the "License Execution Fee"). 3.2.2 A non-refundable payment of all of the Licensor's documented out-of-pocket expenses incurred in connection with the transfer of the Technology to the Company or its sublicensee, up to a maximum of $[**]. 3.2.3 A non-refundable milestone payment of $[**], payable as follows: 3.2.3.1 $[**] upon [**] of the Product(s); and 3.2.3.2 $[**] upon [**] of the Product(s) [**].
Consideration for the License. As consideration for the rights granted herein to Licensee, Licensee shall pay to Licensor, upon full execution hereof, a one time license fee (the “License Fee”) of One and No/100 Dollars ($1.00).
Consideration for the License. 5.1 In consideration for the Licensee granted herein, Licensee shall make the following payments to Licensor upon execution of this Agreement: . $XXXXXX (USD) for the pilot plant to be shipped to Temora, New South Wales upon execution of this Agreement (all shipping costs to be paid by the Licensee), . An additional $XXXXX (USD) for the pilot plant upon the earlier of XXXXXX (XX) days from release of the pilot plant from Australian customs or XXXXX (XX) days after delivery of the facility to the designated Australian port In addition, Licensee shall pay a fee of $XXXXXX (USD) as a license fee for two production lines constructed in Australia or New Zealand in the following increments: . $XXXXXX (USD) upon execution of this Agreement and delivery of the plant scope definition for a full scale production line, such plant scope definition to be provided by the Licensor within XXX months of the Effective Date, . $XXXXXX (USD) upon the earlier of XXX XXXX from the date of this Agreement or initiation of construction of the initial full scale production line, . $XXXXXX (USD) upon shipment of first commercial quantity of finished product from the initial production line, . $XXXXXX (USD) upon achievement of an equivalent of XXX% represented capacity production rates from the initial production line, and . $XXXXXX (USD) upon achievement of an equivalent of XXX% represented capacity production rates from the initial production line. The calculation of ties/year shall be in the aggregate for each production line constructed and based upon a weight of XXX pounds per tie. Such amount of ties per year is estimated to be XXXXXX per production line. Should the specifications for Australian composite sleepers be changed by regulatory or other requirement, the calculation of ties/year shall be adjusted appropriately. Payments for each subsequent two production lines constructed in the Licensee Territory shall be as follows: . $XXXXXX (USD) upon initiation of construction of such full scale production lines, . $XXXXXX (USD) upon shipment of first commercial quantity of finished product, . $XXXXXX (USD) upon achievement of an equivalent of 80% represented capacity production rates from one of the production lines, and . $XXXXXX (USD) upon achievement of an equivalent of 100% represented capacity production rates from one of the production lines. In addition to the Licensing fees, TieTek shall be granted, for a nominal investment amount, an option to receive a XX% equity or eq...

Related to Consideration for the License

  • Sublicense Grant Licensee will be entitled to grant Sublicenses to third parties under the license granted pursuant to Section 2.1 subject to the terms of this Section 2.3. Any such Sublicense shall be on terms and conditions in compliance with and not inconsistent with the terms of this Agreement. The grant of a Sublicense shall not in any way diminish or alter Licensee’s obligations under this Agreement.

  • Non-Exclusivity; Survival of Rights; Subrogation (a) The rights of indemnification and advance of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the charter or Bylaws of the Company, any agreement or a resolution of the stockholders entitled to vote generally in the election of directors or of the Board of Directors, or otherwise. Unless consented to in writing by Indemnitee, no amendment, alteration or repeal of the charter or Bylaws of the Company, this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in Indemnitee’s Corporate Status prior to such amendment, alteration or repeal, regardless of whether a claim with respect to such action or inaction is raised prior or subsequent to such amendment, alteration or repeal. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right or remedy shall be cumulative and in addition to every other right or remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion of any right or remedy hereunder, or otherwise, shall not prohibit the concurrent assertion or employment of any other right or remedy. (b) In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.

  • Additional Indemnification Rights Non Exclusivity a. Notwithstanding any other provision of this Agreement, the Company hereby agrees to indemnify the Indemnitee to the fullest extent permitted by law, notwithstanding that such indemnification is not specifically authorized by the other provisions of this Agreement, the Articles, the By-Laws or by statute. b. The provisions for indemnification and advancement of expenses set forth in the Agreement shall not be deemed exclusive of any other rights which Indemnitee may have under any provision of law, the Articles, the By-laws, the vote of the Company’s shareholders or disinterested directors, insurance policies, other agreements or otherwise; and nothing in this Agreement shall be used to interpret or otherwise affect such other rights. Indemnitee’s rights hereunder shall continue after Indemnitee has ceased acting as a director, officer, employee or agent of the Company and shall inure to the benefit of the heirs, executors and administrators of Indemnitee. However, no amendment or alteration after the Effective Date of the Articles or By-laws or any other agreement shall adversely affect the rights provided to Indemnitee under the Agreement.

  • The License 3.1.1 Subject to and in accordance with the terms and conditions set forth in this Agreement, and in particular subject to the due fulfillment of all the obligations assumed towards Maha-Metro by the Licensee, Maha-Metro hereby grants and authorizes the Licensee to the following (the “Specified Purpose”) : a. To have access to Licensed Space(s) during the License Period, develop, finance, commission, operate, manage and maintain the Licensed Space(s) during the License Period at the cost and risk of the Licensee. Any development made by the Licensee on the Licensed Space(s) shall be deemed to be the property of Maha-Metro and all the rights of the Licensee in the Licensed Space(s) shall relinquish in the favour of Maha-Metro. b. Subsequent to the Fitment Period, to utilise the licensed space, at its own costs and risk, for carrying out activities stated at Point No.

  • License Grant If Products include software, firmware or documentation, Supplier grants to DXC a non-exclusive, perpetual, royalty free, worldwide license to use, reproduce, display, prepare derivative works of the documentation and distribute such works, software, firmware or documentation directly or as integrated into DXC products, and to sublicense such rights to third parties. Supplier shall identify all licenses and deliver to DXC all materials required to meet the requirements of any licenses for third party software that is included in the Products. Supplier shall deliver to DXC the source code for any software licensed under a license that has a source availability requirement (such as the GNU General Public License). If the source code is not included with the material that Supplier has previously delivered, Supplier shall deliver within seven (7) days after DXC’s request the source code for any software licensed under an open source license that has a source availability requirement. Supplier grants DXC the right to duplicate and distribute the materials as necessary.